SF3B1 and myelodysplastic syndrome: In contrast to Malcovati et al. [11], we observed that SF3B1 mutations were associated with significantly shorter OS within MDS 5q- concordant with previous reports [19, 22, 23] highlighting the adverse prognostic impact of mutated SF3B1 within this entity.